Donor explorer

GSE206785_Gastric_Cancer_TME

Dataset-level donor/sample index migrated from ImmuneAging into LACA. Open a donor ID to inspect de-identified metadata, source notes, and UMAP preview status.

Browse donors Back to atlas

CIMA_PBMC_Science_2025 COVID19_PBMC Neutrophil_LiverCancer_Nature_2022 SCAR244 HCC_GSE140228_Cell_2019 Thymus_PBMC_NatureAging_2025 CancerSCEM 2.0 LGH_Immunity Fetus_PBMC_Cell_2025 GSE243013_NSCLC_anti_PD1 GSE279452_Sepsis_PBMC GSE134355_Human_Cell_Landscape_HCL GSE316337_Type1_Diabetes_PBMC GSE254249_Rectal_Cancer_TNT GSE206785_Gastric_Cancer_TME GSE182159_HBV_Liver_Blood_Immune GSE189955_HGSC_Multiomics GSE149938_Human_Blood_Cell_Atlas GSE207422_NSCLC_PD1_Chemo GSE221521 GSE255685 GSE182409 Han Chinese serum proteome pQTL / GNHS + WEBIRTH CRC plasma proteomics, Zhejiang discovery cohort RA serum proteomics, Guangzhou MTBLS13155 MTBLS352 MTBLS11996 MTBLS12968 MTBLS12820 MTBLS13501 MTBLS9664 MTBLS5568 Bian_PBMC_NI_2025 LGH_X_Age

PopulationChinese gastric cancer cohort

ModalityscRNA-seq

DataGEO processed files mirrored on pandora002; Tracking donor IDs generated; UMA...

Donor Table

24 rows in this dataset; 50 rows per page.

						Details
HIA-GSE206785-D0001	P171012	64 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0002	P171116	72 years	Female	Treatment-naive gastric cancer; stage I; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0003	P171218	50 years	Female	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0004	P180116	69 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0005	P180118	65 years	Female	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0006	P180123	55 years	Male	Treatment-naive gastric cancer; stage I; MSI/MSS MSS; TCGA group EBV	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0007	P180124	63 years	Female	Treatment-naive gastric cancer; stage IV; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0008	P180129	54 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0009	P180305	66 years	Male	Treatment-naive gastric cancer; stage IV; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0010	P180308	65 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0011	P180605	64 years	Male	Treatment-naive gastric cancer; stage IV; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0012	P180606	68 years	Male	Treatment-naive gastric cancer; stage II; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0013	P180608	86 years	Male	Treatment-naive gastric cancer; stage IV; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0014	P180611	64 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0015	P181019	50 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group EBV	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0016	P181025	81 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0017	P181026	55 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0018	P181217	65 years	Male	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0019	P181227	62 years	Female	Treatment-naive gastric cancer; stage III; MSI/MSS MSI; TCGA group MSI	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0020	P190103	65 years	Male	Treatment-naive gastric cancer; stage II; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0021	P190118	59 years	Female	Treatment-naive gastric cancer; stage II; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0022	P190123	55 years	Male	Treatment-naive gastric cancer; stage I; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0023	P190124	59 years	Male	Treatment-naive gastric cancer; stage I; MSI/MSS MSS; TCGA group CIN	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene
HIA-GSE206785-D0024	P190125	46 years	Female	Treatment-naive gastric cancer; stage III; MSI/MSS MSS; TCGA group GS	stomach tumor and matched adjacent non-tumor normal tissue	UMAP + Gene